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Abstract
Background: Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum are able to infect horses. However,
the extend to which Danish horses are infected and seroconvert due to these two bacteria is unknown. The aim of
the present study was to evaluate the seroprevalence of B. burgdorferi sensu lato and A. phagocytophilum in Danish
horses.
Methods: A total of 390 blood samples collected from all major regions of Denmark and with a geographical
distribution corresponding to the density of the Danish horse population were analyzed. All samples were
examined for the presence of antibodies against B. burgdorferi sensu lato and A. phagocytophilum by the use of the
SNAP®4DX ® ELISA test.
Results: Overall, 29.0% of the horses were seropositive for B. burgdorferi sensu lato whereas 22.3% were
seropositive for A. phagocytophilum.
Conclusions: Antibodies against B burgdorferi sensu lato and A. phagocytophilum are commonly found among
Danish horses thus showing that Danish horses are frequently infected by these organisms.
Background
The vector-borne bacteria Borrelia burgdorferi sensu
lato (B. burgdorferi s. l.) and Anaplasma phagocytophi-
lum infect horses in those parts of the world where
Ixodes spp. are present. It has been estimated that up to
30-40% of horses in an endemic area are seropositive
for B. burgdorferi s. l. [1]. Most of these horses will
remain asymptomatic, while 5-10% of them are likely of
developing clinical signs [1-4]. Similar, a previous study
on A. phagocytophilum, have indicated that up to 50%
of seropositive horses in endemic areas undergo a sub-
clinical infection [5]. It is assumed that clinical equine
granulocytic anaplasmosis is an overseen condition in
most of Europe, as most horses recover spontaneously
and therefore do not attract the attention of clinicians
[6]. In Denmark, B. burgdorferi s. l. and A. phagocytophi-
lum are transferred by the tick Ixodes ricinus. A Danish
study from 2005 revealed that the tick density varies
substantially between different regions of Denmark with
highest density on the island of Bornholm (0.5-1.0 ticks/
min. flagging) followed by Zealand, Funen, Middle-Jut-
land and East-Jutland (0.25-0.5 ticks/min. flagging),
South-Jutland (0.15-0.25 ticks/min. flagging), and West
and North-Jutland (0-0.15 ticks/min. flagging) [7]. An
apparent increase in the tick density from 1984 to 1998
[8] fits well with a positively correlated relationship
between warmer winters and longer spring and autumn
periods and the density of I. ricinus [9,10].
The seroprevalence of B. burgdorferi s. l. and A. pha-
gocytophilum among horses in Denmark has to our
knowledge never been evaluated. Recent European stu-
dies on the seroprevalence of B. burgdorferi s. l. shows a
prevalence of 47.8% seropositive horses in Slovakia [11],
25.6% in Poland [12], 16.8% in Sweden [13], 16.1% in
Germany [14] and 6.3% in Turkey [15]. The seropreva-
lence of A. phagocytophilum in Europe varies from
83.3% in Holland [6], 16.7% in Sweden [13], 11.3% in
France [16], 8.1% in Italy [17,18] to 6.5% in Spain [19].
Furthermore, a Swedish study reported that 4.5% of the
examined horses were seropositive for both B.
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burgdorferi s. l. and A. phagocytophilum [13]. In 2005,
Danish researchers made a seroprevalence study on the
distribution of B. burgdorferi s. l. and A. phagocytophi-
lum antibodies in Danish deer. The overall seropreva-
lence was 36.6% for B. burgdorferi s. l. Significant
regional differences were found when Jutland was com-
pared with the islands (Funen, Zealand, Lolland, Falster
and Bornholm) with a seroprevalence of 27.1% versus
46.7%, respectively. In the case of A. phagocytophilum,
all tested deer in three districts of North-Jutland were
antibody negative although the average seroprevalence
was found to be 42.6% ranging from 39.6% in Jutland to
47.6% of the islands [7].
The aim of the present study was to evaluate the sero-




The sample size was calculated using the following for-
mulas:
n Nx E x
E N n x n N




/ (( ) )
[(( ) / ( )]








where n is the sample size, E is the margin of error, r
is the fraction of response that we are interested in and
Z c( )100 is the critical value for the confidence level of c.
As the prevalence of horses seropositive for B. burg-
dorferi s. l. and A. phagocytophilum vary considerably in
areas comparable to Denmark [11-14], calculations were
based on a situation where the test results from each
individual horse could have 50%-50% test outcome (r =
50%). A difference of more than 5% (E) to the expected
50%-50% outcome with a confidence of 95% (c) should
be detected. Thus, with an estimated population of
200,000 horses (N) in Denmark, a sample size including
384 individuals was proposed. As the test kits came as
pre-packed batches, 390 individual blood samples were
taken.
Selection of horses
No formal randomized selection of horses was applied
but an even representation of samples from all regions
in Denmark was aimed at. Denmark is officially divided
into five administrative regions including the Capital
Region (C), Region Zealand (Z), Region South-Denmark
(SD), Region Central-Jutland (CJ) and Region North-Jut-
land (NJ) (Figure 1). Assuming that the horse population
is evenly distributed between the five regions, a sample
size of 78 horses was used for each region. Within each
region, horses were selected based on availability due to
previous contact to individual horse owners, horse studs
and clinical veterinary practices. Approximately one
third of the samples were obtained from horses
admitted to four equine veterinary clinics. The remain-
ing samples were taken during visits to various size
breeding farms, horse riding schools and farms. No
horses with signs or a recent history of untreated infec-
tious diseases were included.
Serological evaluation of blood samples
A total of 390 blood samples were collected in EDTA
blood collection tubes. All blood samples were analyzed
immediately by a SNAP®4DX ® ELISA test (IDEXX
Laboratories, Taastrup, Denmark) according to the man-
ufactures instructions.
Putative risk factors
Every horse owner was asked to provide information with
regard to putative risk factors including the breed, gen-
der, age, use and housing, respectively. For each factor, 2-
5 categories were established; “no answer” was included
as a category. Gender included mare, stallion and gelding.
Age was classified into groups of 1-4 years, 5-10 years,
11-20 years, and over 21 years. Housing facilities
included pasture and pasture in combination with stabled
housing, and access to pasture in the summer period was
categorized as 1-3 months and >3 months. The horses
were used for breeding, competitions/races, riding school
and for leisure riding. Another risk factor was the use of
the horse; it included the categories not used for riding,
primarily used for leisure riding in the terrain or primar-
ily used on a riding ground. Finally it was noted if the
horse has been used for breeding.
Statistical analyses
The ELISA results and their association with the puta-
tive risk factors were statistically analyzed using the
PROC logistic procedure in SAS 9.1 (SAS Institute,
Cary, NC, USA). A logit-transformation was used to
estimate the relation between the outcome and the
explanatory variables.
The model was given by:
Logit (pi) = a + b(bacteriai) + c(regioni)+ d(genderi) +
e(agei) + f(housingi) + g(pasture in summer periodi)+ h
(breedi) + i(usei) + j(riding typei) + k(breedingi)
Where Pi is the dependent variable thefollowing out-
comes was possible i) B. burgdorferi s. l. ii) A. phagocyto-
philum, iii) B. burgdorferi s. l. or A. phagocytophilum iv)
both B. burgdorferi s. l. and A. phagocytophilum), a is
the intercept, and irefers to the level of categories to the
respective risk factor. The PROC logistic procedure
tested two-way interactions between the different expla-
natory variables (risk factors). From the full model
including all explanatory variables, a backward elimina-
tion was used to exclude non-significant variables. The
parametric statistical Wald test was used to exclude the
most non-significant variables until all variables in the
model were significant.
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To test the difference between the seroprevalence of
B. burgdorferi s. l., A. phagocytophilum and the different
regions, Chi square test or Fischer’s exact test were
used.
All statistical calculations were made with the software
SAS 9.1. The level of significance was set to P < 0.05.
Results
Sampling
The sampled horses consisted of 222 mares, 135 geld-
ings and 33 stallions. The breeds included Icelandic
horse (182), Danish Warmblood (67), Jysk horse (11),
Standardbred (11), Shetland Pony (10), Oldenburg (6),
Friesian (6), Trakehner (5), Hanoverian (5), North Bagge
(5), Connemara (4), Arabs (4) and other/mixed breeds
(74). Horses aged 1 to 30 years (Mean = 9.2 years, SD ±
6.0) were included. All samples were obtained in the
period from the 5th of April to the 11th of May 2009.
The horses sampled originated from herds based in 42
individual postal codes (Figure 1). Of the horses tested
through the participating veterinary clinics, 6-8 were
under treatment and in the late recovery phase of an
antibiotic treatment regimen, whereas the remaining
horses were prophylactic cases including vaccination,
teeth management, and the vast majority were subjected
to assisted reproduction.
Serology
The over-all seroprevalence of B. burgdorferi s. l. was
29.0% and 22.3% for A. phagocytophilum. The highest
seroprevalence of 33.3% for B. burgdorferi s. l. was
found in the Region of South-Denmark while only
24.4% of the samples from Region of North-Jutland
were positive. The highest A. phagocytophilum seropre-
valence (33.3%) was found in the Region of Zealand
while the lowest (16.7%) was found in the Capital
Region. Despite the seemingly high regional differences
in seroprevalence for either organism, this could not be
demonstrated statistically (P ≥ 0.29). The regional sero-








Figure 1 Geographical location of sample sites (stars) within each of the five administrative regions of Denmark. (NJ) Northern Jutland,
(MJ) Mid Jutland, (SJ) Southern Jutland, (Z) Zeeland and (C) Capital region.
Table 1 Seroprevalence of Borrelia burgdorferi sensu lato
and Anaplasma phagocytophilum in 390 Danish horses.
Region Borrelia-positive (%) Anaplasma-positive
(%)
Region North-Jutland 19 (24.4) 18 (23.1)
Region Central-Jutland 21 (26.9) 16 (20.5)
Region South-Denmark 26 (33.3) 14 (18.0)
Region Zealand 25 (32.1) 26 (33.3)
Capital Region 22 (28.2) 13 (16.7)
Denmark (Total) 113 (29.0) 87 (22.3)
A total of 78 horses were sampled from each region.
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There was a considerable with-in region variation of
the seroprevalences e.g. the Capital Region, which had
an overall low seroprevalence for both B. burgdorferi s.
l. and A. phagocytophilum. However, the seroprevalence
for the island Bornholm, which belongs to the Capital
Region was 60% for B. burgdorferi s. l. and 50% for A.
phagocytophilum. Omitting the results from Bornholm,
the Capital Region had a seroprevalence of 17.2% for B.
burgdorferi s. l. and 5.2% for A. phagocytophilum. There
was a significant lower seroprevalence of both B. burg-
dorferi s. l. (P = 0.017) and Anaplasma phagocytophilum
(P < 0.001) in the Capital Region (Bornholm excluded)
compared to Bornholm.
No significant association was found between any of
the proposed risk factors and the occurrence of antibo-
dies against B. burgdorferi s. l. (outcome (i). On the con-
trary, a significant correlation (P ≤ 0.03) was found
between the age of the horses and the presence of A.
phagocytophilum antibodies (outcome ii). Horses aged
11 to 20 years had an odds ratio (OR) of 2.3 (with a
95% confidence interval of 1.2-4.6) for being seropositive
for A. phagocytophilum whereas horses ≥ 21 years had
an OR of 3.3 (with a 95% confidence interval 1.1-10.5)
for being seropositive compared with horses aged 1-4
years, respectively. There was no significant association
between other risk factors and presence of A. phagocyto-
philum antibodies. Eleven percent of the examined
horses were seropositive for both B. burgdorferi s. l. and
A. phagocytophilum. It appeared that the OR for horses
seropositive for B. burgdorferi s. l. was 3.1 (with a 95%
confidence interval of 1.9-5.0) when simultaneously
being seropositive for A. phagocytophilum (outcome iii).
Likewise, the OR for horses seropositive for A. phagocy-
tophilum was 3.3 (with a confidence interval of 1.9-5.4)
for simultaneously being seropositive for B. burgdorferi
s. l. (outcome iii) Thus, there was a significant associa-
tion between the occurrence of antibodies against B.
burgdorferi s. l. and A. phagocytophilum (P ≤ 0.0001)
(outcome iiii) There was no significant association
between the other factors investigated and the occur-
rence of a simultaneous infection with B. burgdorferi s.
l. and A. phagocytophilum.
Discussion
Comparing the seroprevalences of B. burgdorferi s. l. and
A. phagocytophilum with results from neighboring Eur-
opean countries [insert refs], the seroprevalences found
in this study are considerably higher. One important
point explaining this difference could relate to sampling
bias i.e. horses included in our study could have had a
higher exposure risk to infected ticks than the general
population. Although a formal randomized selection of
horses was not applied, the considerable differences in
geographic location, breed, age and use of the horses
sampled is believed to provide a good approximation of
the general horse population in Denmark. Furthermore,
none of the horses included this study were selected
because they exhibited or have had clinical signs of
equine borreliosis or equine granulocytic anaplasmosis.
On the contrary, previous studies have shown a steady
increase in the ticks density, which has been attributed
to climatic changes [8] and an increased infection rate
among the ticks [21], which may prove to be more likely
reasons for the higher prevalences observed. Whether
the differences in the prevalences in Denmark versus
Sweden and Germany [13,14] are due to an increase in
the number of infected ticks since the latter investiga-
tions were performed, or whether the prevalence in
Denmark in fact is higher will however remain unknown
until data from prevalence studies with a comparable
design and method from all countries in the region are
performed. Differences in study design e.g. serological
test method and statistical approach for the analysis of
the results currently makes comparison of previous
results difficult.
The highest density of ticks has previously been found
on Bornholm, whereas a lower density was observed in
the major Danish islands and in Jutland [7]. In addition
to this, a Danish study of the seroprevalence of B. burg-
dorferi s. l. in deer showed that the risk of becoming
infested with a tick positive for B. burgdorferi s. l. was
greatest in the Capital Region followed by the Region of
Zealand and the regions of Jutland, respectively. Inter-
estingly, the risk of a deer being positive for B. burgdor-
feri s. l. antibodies was two times higher for Bornholm
(part of the Capital Region) than for the island Zealand
in general [22]. The present study shows that most of
the horses seropositive for B. burgdorferi s. l. were
found in the Region of South-Denmark followed by the
Region of Zealand, the Capital Region, and Region of
Central-Jutland and the Region of North-Jutland,
thereby largely reflecting the tick density. In cases where
the results did not match the deer study [ref], this may
reflect differences as to the locality sampled within the
regions compared. In accordance with the above, the
study also shows that the prevalence of horses seroposi-
tive for B. burgdorferi s. l. on the island of Bornholm
was two times higher than for Zealand, when the results
for Bornholm was omitted in the overall result of the
Capital Region and the Region of Zealand. We analyzed
blood samples taken during spring, which likely influ-
enced the number of seropositive individuals negatively
as the likelihood of becoming seropositive later during
the summer and autumn due to a longer exposure and
risk of being infested by an infected tick [13].
The SNAP®4DX ® test was developed for screening of
Dirofilaria immitis antigen and antibodies to A. phago-
cytophilum, B. burgdorferi and Ehrlichia canis in canine
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serum, plasma or whole blood [23,24]. However,
SNAP®4DX ® has previously been evaluated and found
useful to detect antibodies against B. burgdorferi s. l.
and A. phagocytophilum in equine samples [23]. Com-
pared to Western immunoblot, the SNAP®4DX ® was
found to have a sensitivity of 100% and a specificity of
95% for detection of antibodies against B. burgdorferi s.
l. in equine samples. Detecting A. phagocytophilum anti-
bodies in equines by the SNAP® 4DX ® test comparison
to the indirect immunofluorescence assay showed a sen-
sitivity and a specificity of 100% [25]. Johnson et al. [ref]
found the SNAP®4DX ® test less sensitive (63%) yet 100%
specific when comparing it to Western blotting and a
C6-ELISA during a longer course of experimental infec-
tion [28]. By using ELISA in the form of a SNAP®4DX®
test it should be noted that this method detects both
active and previous infections with measurable antibody
levels [20]. From previous studies, the antibody levels in
horses have been found detectable for up to 2 years
[20,26]. In these, the clinically affected horses had the
highest ELISA titers compared to horses with subclinical
infections [1]. From studies with horses experimentally
infected with B. burgdorferi s. l. and subsequently ana-
lyzed by ELISA, it appeared that even in cases where
the horses had no clinical signs, antibodies were
detected within 5-6 weeks. Antibody levels rose to a
maximum over the following 3-4 months after which
they remained static for at least 9 months [27]. How-
ever, another study has shown that individual horses,
despite being positive by PCR and cell culture, did not
remain seropositive by the SNAP®4DX® test over a per-
iod of 9 months [28]. The above indicates that the anti-
body level may be detectable by some ELISA tests at
least 9 months post-infection with B. burgdorferi s. l.
but presumably for a shorter period using the
SNAP®4DX® test. Experimental infections in horses
inoculated intravenously with A. phagocytophilum
resulted in seroconversion 6-8 days post inoculation and
achieved a maximum ELISA titer at day 10-30. The
antibodies remained detectable for up to 5 months [28].
It is well established that horses acquiring a natural
infection with A. phagocytophilum mount a slower anti-
body response, likely since the burden of infection typi-
cally is lower and delivered over a prolonged period
[29]. Despite a longer incubation period, prior serocon-
version from a natural infection versus the intravenously
administered infections, the antibody levels were similar
after 30 days [30]. Therefore, it is reasonable to assume
that an ELISA may have a positive outcome for up to 5
months post-infection with A. phagocytophilum. The
results found in this study therefore likely reflect the
proportion of horses that have been infected with B.
burgdorferi s. l. within the last 9 months or A. phagocy-
tophilum within the last 5 months from the time of
sampling and not only horses with an active infection at
the time of blood sampling.
Conclusions
The present study demonstrates that antibodies against
B. burgdorferi s. l. and A. phagocytophilum can be com-
monly found in Danish horses. The findings warrant
further attention to these infections in horses particu-
larly with regard to improved means for detection of
active infections, which may contribute to a better gen-
eral understanding of these diseases and their impact on
horse behavior and welfare.
Acknowledgements
Idexx Laboratories and Kruuse A/S are thanked for providing discounted
ELISA kits.
Author details
1Department of Veterinary Disease Biology, Faculty of Life Sciences,
University of Copenhagen, Stigbøjlen 4, DK-1870 Frederiksberg C, Denmark.
2Department of Large Animal Sciences, Faculty of Life Sciences, University of
Copenhagen, Dyrlægevej 68, DK-1870 Frederiksberg C, Denmark.
Authors’ contributions
MGBH participated in the design of the study and carried out the sampling
and ELISA tests, contributed to the statistical analysis and drafted the
manuscript. MC and LRT performed the statistical analysis. MRP participated
in the design of the study and helped to draft the manuscript. AMB
participated in the design of the study, coordinated the activities and
helped to draft the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 28 September 2009
Accepted: 18 January 2010 Published: 18 January 2010
References
1. Manion TB, Bushmich SL, Mittel L, Laurendeau M, Werner H, Reilly M: Lyme
disease in horses: Serological and antigen testing differences. 44th
Proceedings of the Annual Convention of the AAEP: 6-9 December 1998;
Baltimore Manion TB, Bushmich SL 1998, 144-145.
2. Bushmich SL: Lyme borreliosis in domestic animals. J Spiro Tick Dis 1994,
1:24-28.
3. Magnarelli LA, Anderson JF, Shaw E, Post JE, Palka FC: Borreliosis in equids
in northeastern United States. Am J Vet Res 1988, 49:359-362.
4. Myhre G, Orcutt R: Lyme disease: Insight into prevalence diagnosis and
treatment. J Equi Vet Sci 2008, 28:390-391.
5. Madigan JE, Hietala S, DeRock E: Seroepidemiologic survey of antibodies
to Ehrlichia equi in horses of northern California. J Am Vet Med Assoc
1990, 196:1962-1964.
6. Butler CM, Nijhof AM, Jongejan F, Kolk van der JH: Anaplasma
phagocytophilum infection in horses in the Netherlands. Vet Rec 2008,
162:216-217.
7. Skarphédinsson S, Jensen PM, Kristiansen K: Survey of tickborne infections
in Denmark. Emerg Infect Dis 2005, 11:1055-1061.
8. Jensen PM, Frandsen F: Temporal risk assesment for Lyme borreliosis in
Denmark. Scand J Infect Dis 2009, 32:539-544.
9. Bennet L, Halling A, Berglund J: Increased incidence of Lyme borreliosis in
southern Sweden following mild winters and during warm humid
summers. Euro J Clin Microbiol Infect Dis 2006, 25:426-432.
10. Lindgren E, Tälleklint L, Polfeldt T: Impact of climatic change on the
northern latitude limit and population density of the disease-
transmitting European tick Ixodes ricinus. Environ Health Perspect 2000,
108:119-123.
Hansen et al. Acta Veterinaria Scandinavica 2010, 52:3
http://www.actavetscand.com/content/52/1/3
Page 5 of 6
11. Stefancíková A, Derdáková M, Škardová I, Szestáková E, Cisláková L,
Kovácová D, Stanko M, Petko B: Prevalence of antibodies to Borrelia
burgdorferi in horses of east Slovakia. Vet Med Czech 2000, 45:227-231, [in
Czech].
12. Stefanciková A, Adaszek L, Petko B, Winiarczyk S, Dudinák V: Serological
evidence of Borrelia burgdorferi sensu lato in horses and cattle from
Poland and diagnostic problems of Lyme borreliosis. Ann Agric Environ
Med 2008, 15:37-43.
13. Egenvall A, Franzén P, Gunnarsson A, Engvall EO, Vågsholm I, Wikström UB,
Artursson K: Cross-sectional study of the seroprevalence to Borrelia
burgdorferi sensu lato and granulocytic Ehrlichia spp. and demographic,
clinical and tick-exposure factors in Swedish horses. Prev Vet Med 2001,
49:191-208.
14. Käsbohrer A, Schönberg A: Serologic studies of the occurrence of Borrelia
burgdorferi in domestic animals in Berlin (West). Berl Münch Tierärztl
Wochenschr 1990, 103:374-378, [in German].
15. Bhide M, Yilmaz Z, Golcu E, Torun S, Mikula I: Seroprevalence of anti-
Borrelia burgdorferi antibodies in dogs and horses in Turkey. Ann Agric
Environ Med 2008, 15:85-90.
16. Leblond A, Pradier S, Pitel PH, Fortier G, Boireau P, Chadoeuf J, Sabatier P:
An epidemiological survey of equine anaplasmosis (Anaplasma
phagocytophilum) in southern France. Rev Sci Tech 2005, 24:899-908, [in
French].
17. Passamonti F, Fabrizia V, Katia C, Stefano C, Giacomo C, Luisa MM,
Daniela PF, Andrea VS, Mauro C: Anaplasma phagocytophilum in horses
and ticks: A preliminary survey of central Italy. Comp Immunol Microbiol
Infect Dis 2010, 33:73-83.
18. Torina A, Vicente J, Alongi A, Scimeca S, Turlá R, Nicosia S, DiMarco V,
Caracappa S, de la Fuente J: Observed prevalence of tick-borne
pathogens in domestic animals in Sicily, Italy during 2003-2005.
Zoonoses Public Health 2007, 54:8-15.
19. Amusategui I, Sainz A, Tesouro MA: Serological evaluation of Anaplasma
phagocytophilum infection in livestock in northwestern Spain. Ann N Y
Acad Sci 2006, 1078:487-490.
20. Dessau RB, Bangsborg JM, Ejlertsen T, Hansen K, Lebech A, Østergaard C:
Laboratory diagnostics of infections caused by Borrelia burgdorferi.
Ugeskr Læger 2006, 168:2805-2807, [in Danish].
21. Vennestrøm J, Egholm H, Jensen PM: Occurrence of multiple infections
with different Borrelia burgdorferi genospecies in Danish Ixodes ricinus
nymphs. Parasitol Int 2008, 57:32-37.
22. Jensen PM, Hansen H, Frandsen F: Spartial risk assesment for Lyme
borreliosis in Denmark. Scand J Infect Dis 2000, 32:545-550.
23. IDEXX Laboratories: Package Insert. 2009http://www.idexx.com/
animalhealth/testkits/4dx/060505707.pdf.
24. IDEXX Laboratories: SNAP 4Dx Test. 2009http://www.idexx.com/
animalhealth/testkits/4dx/.
25. Chandrashekar R, Daniluk D, Moffitt S, Williams J: Serologic diagnosis of
equine borreliosis: Evaluation of an in-clinic enzyme-linked
immunosorbent assay (SNAP 4Dx). Intern J Appl Res Vet Med 2008, 6:145-
150.
26. Reed SM, Bayly WM, Sellon DC: Equine Internal Medicine Louis: Saunders, 1
2004.
27. Chang YF, Novosol V, McDonough SP, Chang C-F, Jacobson RH, Divers T,
Quimby FW, Shin S, Lein DH: Experimental infection of ponies with
Borrelia burgdorferi by exposure to Ixodid ticks. Vet Pathol 2000, 37:68-76.
28. Johnson AL, Divers TJ, Chang Y-F: Validation of an in-clinic enzyme-linked
immunosorbent assay kit for diagnosis of Borrelia burgdorferi infection in
horses. J Vet Diagn Invest 2008, 20:321-324.
29. Pusterla N, Lutz H, Braun U: Experimental infection of four horses with
Ehrlichia phagocytophila. Vet Rec 1998, 143:303-305.
30. Franzén P, Aspan A, Egenvall A, Gunnarsson A, Åberg L, Pringle J: Acute
clinical, hematologic, serologic and polymerase chain reaction findings
in horses experimentally infected with a European strain of Anaplasma
phagocytophilum. J Vet Intern Med 2005, 19:232-239.
doi:10.1186/1751-0147-52-3
Cite this article as: Hansen et al.: Seroprevalence of Borrelia burgdorferi
sensu lato and Anaplasma phagocytophilum in Danish horses. Acta
Veterinaria Scandinavica 2010 52:3.
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Hansen et al. Acta Veterinaria Scandinavica 2010, 52:3
http://www.actavetscand.com/content/52/1/3
Page 6 of 6
